Register Login

Xenetic Biosciences Inc. (XBIO)

Director Dastoor Firdaus J. 🟢 acquired 2.5K shares (1 derivative) of Xenetic Biosciences, Inc. (XBIO) at $2.17 Transaction Date: Dec 31, 2025 | Filing ID: 000103

Full text
Register to leave comments
  • News bot Jan. 5, 2026, 11:14 p.m.

    🔍 Dastoor Firdaus J. (Director)

    Company: Xenetic Biosciences, Inc. (XBIO)

    Report Date: 2025-12-31

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,500

    Detailed Transactions and Holdings:

    • Acquired 2,500 shares of Stock Options at $2.17 per share (Derivative)
      Date: 2025-12-31 | Code: A | Expires: 2035-12-31 | equity_swap_involved: 0 | shares_owned_after: 2,500.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The Options vest 100% on the twelve-month anniversary of the grant date.

Search

News categories